A launch that was never clinically defensible, or the month-eight compliance failure no one was tracking. Med Strat Pro is the embedded medical leadership built to prevent both.
A chief medical officer is the translator between what the business wants to sell and what doctors can responsibly prescribe. And the protector who keeps the company defensible at launch and stable long after it.
Your contracted doctor network handles the prescribing layer. It does not, and cannot, cross into corporate practice of medicine on your behalf. That is a separate function, and it is a large one.
Med Strat Pro fills it. The work sits adjacent to your prescribing infrastructure, supports it with cleaner protocols and packaged products, and frees your doctors to do what they do best without asking them to also be marketing reviewers and regulatory analysts.
Engagements are scoped to what your platform actually needs. Pricing is set after an intro call, not guessed from a list.
The 2026 FDA advisory committee will reshape which peptide compounds can be marketed. Most operators will scramble once the decision lands. Med Strat Pro tracks the proceedings now and maintains ready-to-deploy protocols for the compounds most likely to clear, so your platform launches on a clean, defensible footing while competitors are still reading the ruling.
The corporate medical function. Protocol oversight, intake architecture, product strategy, and the translation layer between what the business sells and what doctors can responsibly prescribe.
Embedded leadership300+ protocol pathways across hormones (testosterone, estrogen, progesterone, DHEA, thyroid), GLP-1 and weight loss, peptides, NAD+, and longevity, all with conditional intake logic.
Adapt, don't rebuildSchedule III and TRT programs across all 50 states. Intake design, prescribing safeguards, audit trail, MSO/PC structure, and physician licensure strategy as the network scales.
50-state coverageSourcing, vetting, and redundancy for compounding partners, including CA 503A sterile compounding, against defined standards for USP 797/800 compliance, board record, and capacity.
Sourcing and redundancyCompound evaluation, cross-sell and package design across hormones, peptides, GLP-1, NAD+, supplements, and diagnostics, cost-basis analysis, and a repeatable risk framework for novel launches in today's strict regulatory environment.
See it three steps outFDA and FTC review of every page, email, and ad, plus website medical content and disclaimers, so claims defensibility scales with revenue instead of against it.
FDA / FTC defensibleLegitScript certification is the gate to payment processing and ad platforms for telehealth and pharmacy operators. Getting it, keeping it, recovering it, and watching for the drift in between are four different problems. Med Strat Pro handles all four.
Guiding new applicants through the full LegitScript application: documentation, clinical and pharmacy alignment, and the operational evidence reviewers expect before approval.
Managing the renewal cycle so certification never lapses. Standards shift between cycles, and the engagement keeps your protocols and disclosures current ahead of each review.
Rebuilding and reapplying after a certification is lost or denied. A clear remediation plan that resolves the underlying findings, then a clean resubmission backed by corrected operations.
Continuous compliance and LegitScript-adjacent risk monitoring between cycles. The failure that ends operators is rarely the launch. It surfaces around month eight, in a drifted protocol or an unreviewed claim, and the engagement is built to catch it first.
A clear path from first call to active medical leadership, without a 30-day ramp spent mapping your org.
A working session, not a sales pitch. We map your stack, your exposure, and where medical leadership moves the needle first.
A written proposal within days of the call, scoped to what you and your team actually need. Defined deliverables, defined cadence.
A 90-day initial term to build the foundation: protocols, compliance posture, and the operational playbook for your network.
Month-to-month thereafter. Ongoing claims review, risk monitoring, and product strategy as the platform scales.
Med Strat Pro is a physician leadership team with more than a decade in independent, multi-state telehealth going back to 2014. The team has founded clinical operations, served as chief medical officers over large physician networks, and built the protocol and compliance infrastructure behind DTC men's and women's health, HRT, peptide, GLP-1, and longevity platforms.
The work is operational, not theoretical. The result is a partner who is useful from week one rather than spending the first month mapping the org.
Short, practical pieces on the regulatory and operational questions we see most often. Available on request.
Where peptides sit between research-use, 503A compounding, and the FDA's evolving posture. A framework for operators launching, expanding, or staying in the category.
Request the paper →Most telehealth platforms do not fail at launch. They fail eight months in, when traffic is up and the compliance layer is showing its age.
Request the paper →Hiring physicians to write prescriptions is not the same as having medical leadership. Why the distinction matters legally, and what structure looks like when done right.
Request the paper →A secure client portal where every engagement, deliverable, and document lives in one place.
Log in and see a tab for each engagement, with live progress on every deliverable, milestone, and document.
An initial call is the fastest way to scope an engagement. We map your platform, your exposure, and where the work begins. All inquiries are handled in confidence.